Details for New Drug Application (NDA): 085121
✉ Email this page to a colleague
NDA 085121 describes MEPERIDINE AND ATROPINE SULFATE, which is a drug marketed by Wyeth Ayerst and is included in one NDA. Additional details are available on the MEPERIDINE AND ATROPINE SULFATE profile page.
The generic ingredient in MEPERIDINE AND ATROPINE SULFATE is atropine sulfate; meperidine hydrochloride. There are twenty-three drug master file entries for this compound. Additional details are available on the atropine sulfate; meperidine hydrochloride profile page.
The generic ingredient in MEPERIDINE AND ATROPINE SULFATE is atropine sulfate; meperidine hydrochloride. There are twenty-three drug master file entries for this compound. Additional details are available on the atropine sulfate; meperidine hydrochloride profile page.
Summary for 085121
| Tradename: | MEPERIDINE AND ATROPINE SULFATE |
| Applicant: | Wyeth Ayerst |
| Ingredient: | atropine sulfate; meperidine hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 0.4MG/ML;50MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 0.4MG/ML;75MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 003
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 0.4MG/ML;100MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
